Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Milinkovic

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Antiviral Therapy|May 28, 2005
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patientsMontse Laguno, Ana Milinkovic, Elisa de Lazzari, et al.
Antiviral Therapy|June 27, 2007
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patientsAna Milinkovic, Esteban Martinez, Sonia López, et al.
International Journal of STD & AIDS|April 20, 2019
Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individualsDavide De Francesco, Alan Winston, Jonathan Underwood, et al.
Therapeutic Drug Monitoring|November 23, 2011
Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant womenMaria Martinez-Rebollar, Montserrat Lonca, Iñaki Perez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 4, 2008
Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patientsMaria Larrousse, Montserrat Laguno, Marta Segarra, et al.
Antiviral Therapy|December 3, 2003
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitorsEsteban Martínez, Pere Domingo, Esteban Ribera, et al.
AIDS (London, England)|August 19, 2004
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patientsMontserrat Laguno, Javier Murillas, José Luis Blanco, et al.
AIDS Research and Therapy|May 2, 2024
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participantsSara Bohnstedt Mørup, Preston Leung, Cavan Reilly, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
Hepatology (Baltimore, Md.)|December 18, 2008
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patientsMontserrat Laguno, Carmen Cifuentes, Javier Murillas, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Antiviral Therapy|May 28, 2005
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patientsMontse Laguno, Ana Milinkovic, Elisa de Lazzari, et al.
Antiviral Therapy|June 27, 2007
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patientsAna Milinkovic, Esteban Martinez, Sonia López, et al.
International Journal of STD & AIDS|April 20, 2019
Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individualsDavide De Francesco, Alan Winston, Jonathan Underwood, et al.
Therapeutic Drug Monitoring|November 23, 2011
Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant womenMaria Martinez-Rebollar, Montserrat Lonca, Iñaki Perez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 4, 2008
Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patientsMaria Larrousse, Montserrat Laguno, Marta Segarra, et al.
Antiviral Therapy|December 3, 2003
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitorsEsteban Martínez, Pere Domingo, Esteban Ribera, et al.
AIDS (London, England)|August 19, 2004
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patientsMontserrat Laguno, Javier Murillas, José Luis Blanco, et al.
AIDS Research and Therapy|May 2, 2024
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participantsSara Bohnstedt Mørup, Preston Leung, Cavan Reilly, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
Hepatology (Baltimore, Md.)|December 18, 2008
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patientsMontserrat Laguno, Carmen Cifuentes, Javier Murillas, et al.
Pageof 8